2-(3-methylbutyl)-7H-purin-6-amine | 97856-37-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并嘧啶类
• 英文名称: 2-(3-methylbutyl)-7H-purin-6-amine
• CAS: 97856-37-6
• 化学式: C₁₀H₁₅N₅
• 分子量: 205.26
• InChiKey: VDRACTHWBNITQP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  80.5
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• [EN] NUCLEIC ACID CHEMICAL MODIFICATIONS<br/>[FR] MODIFICATIONS CHIMIQUES D'ACIDE NUCLÉIQUE
  申请人：ALNYLAM PHARMACEUTICALS INC

  公开号：WO2010101951A1

  公开（公告）日：2010-09-10

  he present invention provides nucleosides of formula (1) and oligonucleotides comprising at least on nucleoside of formula (2): Another aspect of the invention relates to a method of inhibiting the expression of a gene in cell, the method comprising (a) contacting an oligonucleotide of the invention with the cell; and (b) maintaining the cell from step (a) for a time sufficient to obtain degradation of the mRNA of the target gene.

  本发明提供了式（1）的核苷和包含至少一种式（2）核苷的寡核苷酸；发明的另一个方面涉及一种抑制细胞中基因表达的方法，该方法包括（a）将本发明的寡核苷酸与细胞接触；和（b）维持步骤（a）中的细胞足够长的时间以获得目标基因mRNA的降解。
• Kinase inhibitors
  申请人：——

  公开号：US20040019210A1

  公开（公告）日：2004-01-29

  This invention provides phenyl-substituted pyrimidopyrimidines, dihydropyrimido-pyrimidines, pyridopyrimidines, naphthyridines, and pyridopyrazines of the general formula: 1 that inhibit cyclin-dependent kinase and tyrosine kinase enzymes, methods and intermediate compounds for their synthesis, as well as pharmaceutical compositions and methods for their use in treating, inhibiting or preventing maladies associated with cell proliferative disorders, including angiogenesis, atherosclerosis, restenosis, and cancer.

  本发明提供了抑制周期蛋白依赖性激酶和酪氨酸激酶酶的通用公式： 1 的苯基取代嘧啶嘧啶、二氢嘧啶嘧啶、嘧啶嘧啶、萘啶和嘧啶吡唑，以及用于合成它们的中间化合物、药物组合物和用于治疗、抑制或预防与细胞增殖紊乱相关的疾病，包括血管生成、动脉粥样硬化、再狭窄和癌症。
• PROTECTED MONOMER AND METHOD OF FINAL DEPROTECTION FOR RNA SYNTHESIS
  申请人：Dellinger Douglas J.

  公开号：US20100076183A1

  公开（公告）日：2010-03-25

  A nucleoside monomer that is protected by a thionocarbamate protecting group is provided, as well as a method for making a polynucleotide that uses the same. Also provided is a polynucleotide synthesis method that employs a diamine to deprotect a protected polynucleotide.

  提供了一种由硫代氨基甲酸酯保护基保护的核苷单体，以及使用该核苷单体制备多核苷酸的方法。还提供了一种利用二胺去保护受保护多核苷酸的多核苷酸合成方法。
• [EN] 2'-O-AMINOOXYMETHYL NUCLEOSIDE DERIVATIVES FOR USE IN THE SYNTHESIS AND MODIFICATION OF NUCLEOSIDES, NUCLEOTIDES AND OLIGONUCLEOTIDES<br/>[FR] DÉRIVÉS DE 2'-O-AMINOOXYMÉTHYL NUCLÉOSIDE POUR L'UTILISATION DANS LA SYNTHÈSE ET LA MODIFICATION DE NUCLÉOSIDES, NUCLÉOTIDES ET OLIGONUCLÉOTIDES
  申请人：US HEALTH

  公开号：WO2012138530A1

  公开（公告）日：2012-10-11

  Disclosed are O-protected compounds of the formula (I):wherein B is an optionally protected nucleobase, and R1-R3 are as described herein, a method of preparing such compounds, and a method of preparing oligonucleotides such as RNA starting from such compounds. The O-protected compounds have one or more advantages, for example, the 2'-O-protected compound is stable during the various reaction steps involved in oligonucleotide synthesis; the protecting group can be easily removed after the synthesis of the oligonucleotide, for example, by reaction with tetrabutylammonium fluoride; and/or the O-protected groups do not generate DNA/RNA alkylating side products, which have been reported during removal of 2'-O-(2-cyanoethyl)oxymethyl or 2'-O-[2-(4-tolylsulfonyl)ethoxymethyl groups under similar conditions.

  揭示了公式（I）中的O-保护化合物：其中B是可选择保护的核碱基，R1-R3如本文所述，一种制备这种化合物的方法，以及一种从这种化合物开始制备寡核苷酸（如RNA）的方法。这些O-保护化合物具有一个或多个优点，例如，2'-O-保护化合物在寡核苷酸合成中涉及的各种反应步骤中是稳定的；保护基在寡核苷酸合成后可以轻松去除，例如，通过与四丁基氟化铵反应；和/或O-保护基在类似条件下去除2'-O-(2-氰乙基)氧甲基或2'-O-[2-(4-甲苯磺酰基)乙氧甲基基团时不会产生已报道的DNA/RNA烷基化副产物。
• [EN] MEK INHIBITING OXA- AND THIA-DIAZOL-2-YL PHENYLAMINE DERIVATES<br/>[FR] DERIVES D'OXA- ET THIA-DIAZOL-2-YL PHENYLAMINE A INHIBITION DE MEK
  申请人：WARNER LAMBERT CO

  公开号：WO2004056789A1

  公开（公告）日：2004-07-08

  This invention provides substituted Phenyl-(2-[1,3,4]thiadiazol-2-yl­phenyl)-amine and (2-[1,3,4]Oxadiazol-2-yl-phenyl)phenyl-amine compounds which act as inhibitors of MAPKIERK Kinase ('MEK') enzymes and pharmaceutical compositions and methods for their use in immunomodulation and in the treatment and alleviation of inflammation, and proliferative diseases such as cancer and restenosis.

  这项发明提供了取代苯基-(2-[1,3,4]噻二唑-2-基苯基)-胺和(2-[1,3,4]噁二唑-2-基苯基)苯基胺化合物，这些化合物作为MAPK/ERK激酶（'MEK'）酶的抑制剂，以及在免疫调节和治疗缓解炎症、癌症和再狭窄等增殖性疾病中使用的药物组合物和方法。